Skip to main content
WeightCited

Omega-3 ： Metabolic Syndrome

B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

B

結論

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label
Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …
Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome

対象集団: Patients with psoriatic arthritis

Randomized Controlled Trial n=45 16 weeks
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.
Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles

対象集団: MetSyn patients vs healthy controls

Key Statistics

44

研究数

3000

参加者数

↑

Positive

B

グレード

Referenced Papers

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. RCT
Advances in rheumatology … 2024
A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. Review
Biochemistry and biophysics … 2023 66 件の引用
Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". Other
Clinical nutrition (Edinburgh, … 2022 1 件の引用
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. RCT
Prostaglandins, leukotrienes, and … 2018 38 件の引用
Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Review
Prostaglandins & other … 2015 182 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
250-500 mg EPA+DHA/day
antiinflammatory:
2,000-4,000 mg/day
weightmanagement:
1,000-3,000 mg EPA+DHA/day

上限量： 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

研究で検討された用量

用量 期間 効果 N
Mediterranean diet 12 weeks Positive --
4 g/day P-OM3 16 weeks Positive 45

推奨摂取タイミング： With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

報告されている副作用

  • ⚠ Fishy aftertaste
  • ⚠ GI discomfort
  • ⚠ Increased bleeding time (at high doses)
  • ⚠ Nausea

既知の相互作用

  • ● Blood thinners (may enhance anticoagulant effect at high doses)
  • ● Blood pressure medications (additive effect)
  • ● Orlistat (reduced absorption)

耐容上限摂取量： 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?
Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).
How much Omega-3 should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3?
Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 and Metabolic Syndrome?
We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

に関する他の成分： Metabolic Syndrome

Berberine A Magnesium B Taurine B

Omega-3 他の症状・状態について

Abdominal Fat Reduction B Cortisol-Related Weight Gain C

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Daniele Scherer et al..
      Adv Rheumatol.
      2024.
      Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial.
      doi:10.1186/s42358-024-00389-5
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Seema Mehdi et al..
      Biochem Biophys Rep.
      2023.
      A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.
      doi:10.1016/j.bbrep.2023.101571
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Jannis Kountouras et al..
      Clin Nutr.
      2022.
      Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events".
      doi:10.1016/j.clnu.2022.06.015
      PubMed
    
    4. 
    
    
  4. 
      [4]
      Gregory C Shearer et al..
      Prostaglandins Leukot Essent Fatty Acids.
      2018.
      Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.
      doi:10.1016/j.plefa.2017.10.006
      PubMed
    
    5. 
    
    
  5. 
      [5]
      Leyre Martínez-Fernández et al..
      Prostaglandins Other Lipid Mediat.
      2015.
      Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
      doi:10.1016/j.prostaglandins.2015.07.003
      PubMed
    
    6. 
    
  















    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。